South African genomics projects are setting a precedent by allocating 10% of their budgets to community-selected initiatives, marking a transformative step in ethical research practices. At the World Congress of Bioethics in Johannesburg, Ngoni Ngwarai, assistant director of systems and operations at the SAMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), outlined a framework for integrating ethical benefit sharing into genomic research. The initiative, detailed in a study published in Nature Communications, highlights efforts by African researchers to ensure local communities derive tangible benefits from their participation in large-scale genetic studies. This year’s World Congress of Bioethics, held for the first time on African soil, underscored the significance of the continent’s rich genetic diversity and the role of African genomic data in advancing global medical science. Despite these contributions, many communities have historically received little or no return from the research they enabled. Ngwarai emphasized that the study, titled “From urban NPOs to rural knowledge networks: applying benefit-sharing models to African genomics research,” offers practical strategies for embedding ethical principles into research processes. The study, led by researchers from the University of the Witwatersrand, examines two major genomics collaborations: the Southern African Blood Regulatory (SABR) resource study and the South African arm of the African Research on Kidney Disease (ARK) Consortium. Both projects were fully funded by Variant Bio, a U.S.-based genomics firm collaborating with Wits researchers to develop new treatments based on genetic insights. A key innovation is the allocation of 10% of each project’s budget to support organizations chosen by the local communities. These organizations include initiatives such as portable generator installations for schools, elder care facilities, youth-focused health programs, and communal water tank distributions. The focus is not on compensating individuals for their participation but on fostering long-term community development. According to Ngwarai, the value of genomic data extends well beyond the initial research scope, and communities should have a stake in the ongoing benefits derived from that data. Professor Michèle Ramsay, director of the Sydney Brenner Institute for Molecular Bioscience, noted that the collaboration between African researchers and international firms like Variant Bio allows local populations to directly benefit from scientific advancements. She highlighted the importance of involving communities in defining their own priorities and ensuring transparency in decision-making processes. The approach represents a broader shift in research ethics, moving away from a model of research conducted on communities toward one where communities actively participate in shaping outcomes. Researchers established consultation mechanisms that enable communities to identify their needs, select beneficiary organizations, and monitor how funds are used. This participatory model ensures that the benefits of research align with the specific needs and aspirations of the communities involved. However, the researchers caution that there is no one-size-fits-all solution. Each community has unique challenges and priorities, requiring tailored approaches to benefit sharing. They stress that while the current model shows promise, implementation requires careful planning, cultural sensitivity, and sustained engagement with local stakeholders. As these initiatives gain traction, they signal a potential paradigm shift in how genomic research is conducted and valued globally. By prioritizing community input and long-term impact, South African genomics projects are not only enhancing scientific integrity but also fostering trust and equity in research partnerships. The success of these models could influence future research frameworks, encouraging more inclusive and ethically grounded practices worldwide.
1 izvještaja
Phys.orgNeovisanSredinaČinjenice 75Objektivnost 85prije 3 dana Južnoafrički projekti genomike usmjeravaju 10% proračuna na dobrobiti koje odabere zajednicaU članku se govori o tome kako su južnoafrički genomički projekti, posebno inicijative SABR i ARK, dodijelili 10% svojih proračuna na dobrobiti koje je odabrala zajednica umjesto pojedinačnih naknada. Ti projekti imaju za cilj osigurati da zajednice uključene u genomsko istraživanje dobiju dugoročne prednosti od svog sudjelovanja. Inicijativa je istaknuta na Svjetskom kongresu bioetike u Johanesburgu, gdje je Ngoni Ngwarai, istraživač sa Sveučilišta Witwatersrand, predstavio nalaze iz studije objavljene u Nature Communications. Studija naglašava donošenje odluka pod vodstvom zajednice u dijeljenju koristi, s naglaskom na održivim poboljšanjima kao što su prijenosni generatori za škole, domovi za starije i distribucija rezervoara za vodu.
Procjena pristranosti (Sredina): Članak predstavlja uravnotežen pregled etičkog okvira koji stoji iza podjele koristi u genomskom istraživanju, naglašavajući uključenost zajednice i dugoročnu održivost.
Zašto činjenice (75): The article discusses South African genomics projects and their benefit-sharing initiatives but does not directly address the ARK Consortium's kidney disease research in Mpumalanga. It references ARK in passing but lacks specific details about the kidney disease study mentioned in the primary source
Zašto objektivnost (85): The article maintains a neutral tone overall, presenting information about benefit-sharing practices in genomics research. However, it emphasizes the ethical aspects and community engagement more than the scientific objectives of the ARK project itself, which may slightly skew the focus away from th
★
Neka vijesti ostanu poštene.
ObjectiveNews financiraju čitatelji i bez oglasa je – pristranost vam pokazujemo, ne skrivamo. Podržite neovisno novinarstvo za 5 €/mjesec.
Postani podupiratelj